BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 10 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.36B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in BioNTech SE as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 258
- −18 vs. Q1 2025
- Shares held
- 53.8M
- +2.05M (+4.0%) vs. Q1 2025
- Total value
- $5.72B
- +$1.01B (+21.5%) vs. Q1 2025
- New holders
- 33
- 84 more added
- Sold out
- 51
- 82 more reduced
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $4.36B |
| Q1 2026 | 274 | $4.22B |
| Q4 2025 | 285 | $4.56B |
| Q3 2025 | 254 | $4.97B |
| Q2 2025 | 258 | $5.72B |
| Q1 2025 | 279 | $4.71B |
| Q4 2024 | 303 | $5.79B |
| Q3 2024 | 297 | $5.24B |
| Q2 2024 | 286 | $3.30B |
| Q1 2024 | 287 | $3.78B |
| Q4 2023 | 282 | $4.28B |
| Q3 2023 | 252 | $4.01B |
| Q2 2023 | 253 | $4.05B |
| Q1 2023 | 282 | $4.88B |
| Q4 2022 | 320 | $5.97B |
| Q3 2022 | 264 | $5.01B |
| Q2 2022 | 293 | $4.99B |
| Q1 2022 | 286 | $5.90B |
| Q4 2021 | 355 | $9.08B |
| Q3 2021 | 336 | $10.0B |
| Q2 2021 | 284 | $7.84B |
| Q1 2021 | 226 | $3.25B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding BioNTech SE; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Brown, Lisle/Cummings, Inc. | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Golden State Wealth Management, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Highline Wealth Partners LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Halbert Hargrove Global Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Caas Capital Management LP | – | – | – | – | Not filed |
| Credit Agricole S A | – | – | – | – | Not filed |
| Sandy Spring Bank | – | – | – | – | Not filed |